<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32515490</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3468</ISSN><JournalIssue CitedMedium="Internet"><Volume>594</Volume><Issue>17</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>FEBS letters</Title><ISOAbbreviation>FEBS Lett</ISOAbbreviation></Journal><ArticleTitle>Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.</ArticleTitle><Pagination><StartPage>2800</StartPage><EndPage>2818</EndPage><MedlinePgn>2800-2818</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/1873-3468.13858</ELocationID><Abstract><AbstractText>Mutations in the nuclear matrix protein Matrin 3 (MATR3) have been identified in amyotrophic lateral sclerosis and myopathy. To investigate the mechanisms underlying MATR3 mutations in neuromuscular diseases and efficiently screen for modifiers of MATR3 toxicity, we generated transgenic MATR3 flies. Our findings indicate that expression of wild-type or mutant MATR3 in motor neurons reduces climbing ability and lifespan of flies, while their expression in indirect flight muscles (IFM) results in abnormal wing positioning and muscle degeneration. In both motor neurons and IFM, mutant MATR3 expression results in more severe phenotypes than wild-type MATR3, demonstrating that the disease-linked mutations confer pathogenicity. We conducted a targeted candidate screen for modifiers of the MATR3 abnormal wing phenotype and identified multiple enhancers involved in axonal transport. Knockdown of these genes enhanced protein levels and insolubility of mutant MATR3. These results suggest that accumulation of mutant MATR3 contributes to toxicity and implicate axonal transport dysfunction in disease pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. FEBS Letters published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Melody</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Ching Serena</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arndt</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>David Duc</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Woo In</ForeName><Initials>WI</Initials><Identifier Source="ORCID">0000-0001-5373-9819</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maksimovic</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiao Xiao Lily</ForeName><Initials>XXL</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mashiat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hongxian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Kailong</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Jingyao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jialu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Deanna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jihye Rachel</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jooyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bruggen</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Wan Hee</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Aging &amp; Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jeehye</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1945-6684</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEBS Lett</MedlineTA><NlmUniqueID>0155157</NlmUniqueID><ISSNLinking>0014-5793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C518587">MATR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034521">Nuclear Matrix-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005426" MajorTopicYN="N">Flight, Animal</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009135" MajorTopicYN="N">Muscular Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034521" MajorTopicYN="N">Nuclear Matrix-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014921" MajorTopicYN="N">Wings, Animal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
Drosophila
</Keyword><Keyword MajorTopicYN="N">MATR3</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">genetic screen</Keyword><Keyword MajorTopicYN="N">multisystem proteinopathy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32515490</ArticleId><ArticleId IdType="doi">10.1002/1873-3468.13858</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Taylor JP (2015) Multisystem proteinopathy: intersecting genetics in muscle, bone, and brain degeneration. Neurology 85, 658-660.</Citation></Reference><Reference><Citation>Brown RH Jr and Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377, 1602.</Citation></Reference><Reference><Citation>Neary D, Snowden J and Mann D (2005) Frontotemporal dementia. Lancet Neurol 4, 771-780.</Citation></Reference><Reference><Citation>Kimonis VE, Fulchiero E, Vesa J and Watts G (2008) VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta 1782, 744-748.</Citation></Reference><Reference><Citation>Cundy T (2018) Paget's disease of bone. Metabolism 80, 5-14.</Citation></Reference><Reference><Citation>Ralston SH and Taylor JP (2019) Rare inherited forms of Paget's disease and related syndromes. Calcif Tissue Int 104, 501-516.</Citation></Reference><Reference><Citation>Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA, Abramzon Y, Marangi G, Winborn BJ et al. (2014) Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 17, 664-666.</Citation></Reference><Reference><Citation>Mensch A, Meinhardt B, Bley N, Huttelmaier S, Schneider I, Stoltenburg-Didinger G, Kraya T, Muller T and Zierz S (2018) The p. S85C-mutation in MATR3 impairs stress granule formation in Matrin-3 myopathy. Exp Neurol 306, 222-231.</Citation></Reference><Reference><Citation>Nakayasu H and Berezney R (1991) Nuclear matrins: identification of the major nuclear matrix proteins. Proc Natl Acad Sci USA 88, 10312-10316.</Citation></Reference><Reference><Citation>Hibino Y, Ohzeki H, Sugano N and Hiraga K (2000) Transcription modulation by a rat nuclear scaffold protein, P130, and a rat highly repetitive DNA component or various types of animal and plant matrix or scaffold attachment regions. Biochem Biophys Res Commun 279, 282-287.</Citation></Reference><Reference><Citation>Hibino Y, Usui T, Morita Y, Hirose N, Okazaki M, Sugano N and Hiraga K (2006) Molecular properties and intracellular localization of rat liver nuclear scaffold protein P130. Biochim Biophys Acta 1759, 195-207.</Citation></Reference><Reference><Citation>Coelho MB, Attig J, Bellora N, Konig J, Hallegger M, Kayikci M, Eyras E, Ule J and Smith CW (2015) Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J 34, 653-668.</Citation></Reference><Reference><Citation>Rajgor D, Hanley JG and Shanahan CM (2016) Identification of novel nesprin-1 binding partners and cytoplasmic matrin-3 in processing bodies. Mol Biol Cell 27, 3894-3902.</Citation></Reference><Reference><Citation>Salton M, Elkon R, Borodina T, Davydov A, Yaspo ML, Halperin E and Shiloh Y (2011) Matrin 3 binds and stabilizes mRNA. PLoS One 6, e23882.</Citation></Reference><Reference><Citation>Skowronska-Krawczyk D, Ma Q, Schwartz M, Scully K, Li W, Liu Z, Taylor H, Tollkuhn J, Ohgi KA, Notani D et al. (2014) Required enhancer-matrin-3 network interactions for a homeodomain transcription program. Nature 514, 257-261.</Citation></Reference><Reference><Citation>Uemura Y, Oshima T, Yamamoto M, Reyes CJ, Costa Cruz PH, Shibuya T and Kawahara Y (2017) Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells 22, 785-798.</Citation></Reference><Reference><Citation>Zhang Z and Carmichael GG (2001) The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 106, 465-475.</Citation></Reference><Reference><Citation>Banerjee A, Vest KE, Pavlath GK and Corbett AH (2017) Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing. Nucleic Acids Res 45, 10706-10725.</Citation></Reference><Reference><Citation>Giordano G, Sanchez-Perez AM, Montoliu C, Berezney R, Malyavantham K, Costa LG, Calvete JJ and Felipo V (2005) Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death. J Neurochem 94, 808-818.</Citation></Reference><Reference><Citation>Niimori-Kita K, Tamamaki N, Koizumi D and Niimori D (2018) Matrin-3 is essential for fibroblast growth factor 2-dependent maintenance of neural stem cells. Sci Rep 8, 13412.</Citation></Reference><Reference><Citation>Przygodzka P, Boncela J and Cierniewski CS (2011) Matrin 3 as a key regulator of endothelial cell survival. Exp Cell Res 317, 802-811.</Citation></Reference><Reference><Citation>Salton M, Lerenthal Y, Wang SY, Chen DJ and Shiloh Y (2010) Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9, 1568-1576.</Citation></Reference><Reference><Citation>Leblond CS, Gan-Or Z, Spiegelman D, Laurent SB, Szuto A, Hodgkinson A, Dionne-Laporte A, Provencher P, de Carvalho M, Orru S et al. (2016) Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 37, 209.e17-21.</Citation></Reference><Reference><Citation>Lin KP, Tsai PC, Liao YC, Chen WT, Tsai CP, Soong BW and Lee YC (2015) Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 36, 2005.e1-4.</Citation></Reference><Reference><Citation>Muller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D, Senderek J, Weis J, Baum P, Deschauer M et al. (2014) Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 76, 669-680.</Citation></Reference><Reference><Citation>Origone P, Geroldi A, Lamp M, Sanguineri F, Caponnetto C, Cabona C, Gotta F, Trevisan L, Bellone E, Manganelli F et al. (2018) Role of MAPT in pure motor neuron disease: report of a recurrent mutation in Italian patients. Neurodegener Dis 18, 310-314.</Citation></Reference><Reference><Citation>Origone P, Verdiani S, Bandettini Di Poggio M, Zuccarino R, Vignolo M, Caponnetto C and Mandich P (2015) A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient. Amyotroph Lateral Scler Frontotemporal Degener 16, 530-531.</Citation></Reference><Reference><Citation>Xu L, Li J, Tang L, Zhang N and Fan D (2016) MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 38, 218.e3-4.</Citation></Reference><Reference><Citation>Feit H, Silbergleit A, Schneider LB, Gutierrez JA, Fitoussi RP, Reyes C, Rouleau GA, Brais B, Jackson CE, Beckmann JS et al. (1998) Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J Hum Genet 63, 1732-1742.</Citation></Reference><Reference><Citation>Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, Elbracht M, Stendel C, Tournev I, Mihailova V et al. (2009) Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 84, 511-518.</Citation></Reference><Reference><Citation>Yamashita S, Nishikami T, Tawara N, Doki T, Nakajo Y, Matsuo Y, Yonemochi Y, Nagai M, Maeda Y and Ando Y (2015) Analysis of the pathogenesis of vocal cord and pharyngeal weakness with distal myopthy. Neuromuscul Disord 25, S282.</Citation></Reference><Reference><Citation>Tada M, Doi H, Koyano S, Kubota S, Fukai R, Hashiguchi S, Hayashi N, Kawamoto Y, Kunii M, Tanaka K et al. (2018) Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am J Pathol 188, 507-514.</Citation></Reference><Reference><Citation>Boehringer A, Garcia-Mansfield K, Singh G, Bakkar N, Pirrotte P and Bowser R (2017) ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci Rep 7, 14529.</Citation></Reference><Reference><Citation>Gallego-Iradi MC, Clare AM, Brown HH, Janus C, Lewis J and Borchelt DR (2015) Subcellular localization of Matrin 3 containing mutations associated with ALS and distal myopathy. PLoS One 10, e0142144.</Citation></Reference><Reference><Citation>Iradi MCG, Triplett JC, Thomas JD, Davila R, Crown AM, Brown H, Lewis J, Swanson MS, Xu G, Rodriguez-Lebron E et al. (2018) Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Sci Rep 8, 4049.</Citation></Reference><Reference><Citation>Malik AM, Miguez RA, Li X, Ho YS, Feldman EL and Barmada SJ (2018) Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife 7, e35977.</Citation></Reference><Reference><Citation>Moloney C, Rayaprolu S, Howard J, Fromholt S, Brown H, Collins M, Cabrera M, Duffy C, Siemienski Z, Miller D et al. (2018) Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3. Acta Neuropathol Commun 6, 137.</Citation></Reference><Reference><Citation>Zhang X, Yamashita S, Hara K, Doki T, Tawara N, Ikeda T, Misumi Y, Zhang Z, Matsuo Y, Nagai M et al. (2019) Mutant MATR3 mouse model to explain multisystem proteinopathy. J Pathol 249, 182-192.</Citation></Reference><Reference><Citation>Jackson GR (2008) Guide to understanding Drosophila models of neurodegenerative diseases. PLoS Biol 6, e53.</Citation></Reference><Reference><Citation>Reiter LT, Potocki L, Chien S, Gribskov M and Bier E (2001) A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 11, 1114-1125.</Citation></Reference><Reference><Citation>Piccirillo R, Demontis F, Perrimon N and Goldberg AL (2014) Mechanisms of muscle growth and atrophy in mammals and Drosophila. Dev Dyn 243, 201-215.</Citation></Reference><Reference><Citation>Taylor MV (2006) Comparison of muscle development in Drosophila and verebrates. In Muscle Development in Drosophila, pp. 169-203. Springer, New York, NY.</Citation></Reference><Reference><Citation>Casci I and Pandey UB (2015) A fruitful endeavor: modeling ALS in the fruit fly. Brain Res 1607, 47-74.</Citation></Reference><Reference><Citation>McGurk L, Berson A and Bonini NM (2015) Drosophila as an in vivo model for human neurodegenerative disease. Genetics 201, 377-402.</Citation></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467-473.</Citation></Reference><Reference><Citation>Boeynaems S, Bogaert E, Michiels E, Gijselinck I, Sieben A, Jovicic A, De Baets G, Scheveneels W, Steyaert J, Cuijt I et al. (2016) Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci Rep 6, 20877.</Citation></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, Badders N, Valentine M, Miller BL, Wong PC et al. (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129-133.</Citation></Reference><Reference><Citation>Steyaert J, Scheveneels W, Vanneste J, Van Damme P, Robberecht W, Callaerts P, Bogaert E and Van Den Bosch L (2018) FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum Mol Genet 27, 4103-4116.</Citation></Reference><Reference><Citation>Iliadi KG, Gluscencova OB, Iliadi N and Boulianne GL (2018) Mutations in the Drosophila homolog of human PLA2G6 give rise to age-dependent loss of psychomotor activity and neurodegeneration. Sci Rep 8, 2939.</Citation></Reference><Reference><Citation>Inagaki HK, Kamikouchi A and Ito K (2010) Methods for quantifying simple gravity sensing in Drosophila melanogaster. Nat Protoc 5, 20-25.</Citation></Reference><Reference><Citation>Park J, Kim Y, Choi S, Koh H, Lee SH, Kim JM and Chung J (2010) Drosophila Porin/VDAC affects mitochondrial morphology. PLoS One 5, e13151.</Citation></Reference><Reference><Citation>Kim S, Jee K, Kim D, Koh H and Chung J (2001) Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J Biol Chem 276, 12864-12870.</Citation></Reference><Reference><Citation>Bischof J, Maeda RK, Hediger M, Karch F and Basler K (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci USA 104, 3312-3317.</Citation></Reference><Reference><Citation>Venken KJ, He Y, Hoskins RA and Bellen HJ (2006) P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science 314, 1747-1751.</Citation></Reference><Reference><Citation>Brand AH and Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415.</Citation></Reference><Reference><Citation>Martin I, Jones MA and Grotewiel M (2009) Manipulation of Sod1 expression ubiquitously, but not in the nervous system or muscle, impacts age-related parameters in Drosophila. FEBS Lett 583, 2308-2314.</Citation></Reference><Reference><Citation>Gajewski KM and Schulz RA (2010) CF2 represses Actin 88F gene expression and maintains filament balance during indirect flight muscle development in Drosophila. PLoS One 5, e10713.</Citation></Reference><Reference><Citation>Tripathi BK, Surabhi S, Bhaskar PK, Mukherjee A and Mutsuddi M (2016) The RNA binding KH domain of Spoonbill depletes pathogenic non-coding spinocerebellar ataxia 8 transcripts and suppresses neurodegeneration in Drosophila. Biochim Biophys Acta 1862, 1732-1741.</Citation></Reference><Reference><Citation>Droppelmann CA, Keller BA, Campos-Melo D, Volkening K and Strong MJ (2013) Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol Aging 34, 248-262.</Citation></Reference><Reference><Citation>Ma Y, Tang L, Chen L, Zhang B, Deng P, Wang J, Yang Y, Liu R, Yang Y, Ye S et al. (2014) ARHGEF28 gene exon 6/intron 6 junction mutations in Chinese amyotrophic lateral sclerosis cohort. Amyotroph Lateral Scler Frontotemporal Degener 15, 309-311.</Citation></Reference><Reference><Citation>Song Y, Lin F, Ye CH, Huang H, Li X, Yao X, Xu Y and Wang C (2020) Rare, low-frequency and common coding variants of ARHGEF28 gene and their association with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 87, 138.e1-6.</Citation></Reference><Reference><Citation>Chartier A, Benoit B and Simonelig M (2006) A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J 25, 2253-2262.</Citation></Reference><Reference><Citation>Robida MD and Singh R (2003) Drosophila polypyrimidine-tract binding protein (PTB) functions specifically in the male germline. EMBO J 22, 2924-2933.</Citation></Reference><Reference><Citation>Munch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G et al. (2004) Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63, 724-726.</Citation></Reference><Reference><Citation>Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ et al. (2003) Mutant dynactin in motor neuron disease. Nat Genet 33, 455-456.</Citation></Reference><Reference><Citation>Ikenaka K, Kawai K, Katsuno M, Huang Z, Jiang YM, Iguchi Y, Kobayashi K, Kimata T, Waza M, Tanaka F et al. (2013) dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration. PLoS One 8, e54511.</Citation></Reference><Reference><Citation>Jiang YM, Yamamoto M, Tanaka F, Ishigaki S, Katsuno M, Adachi H, Niwa J, Doyu M, Yoshida M, Hashizume Y et al. (2007) Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 66, 617-627.</Citation></Reference><Reference><Citation>Drubin DG and Kirschner MW (1986) Tau protein function in living cells. J Cell Biol 103, 2739-2746.</Citation></Reference><Reference><Citation>Weingarten MD, Lockwood AH, Hwo SY and Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72, 1858-1862.</Citation></Reference><Reference><Citation>Lin HC, Lin CH, Chen PL, Cheng SJ and Chen PH (2017) Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p. R5H mutation: a case report and literature review. BMC Neurol 17, 186.</Citation></Reference><Reference><Citation>Strafela P, Plesko J, Magdic J, Koritnik B, Zupan A, Glavac D, Bresjanac M and Popovic M (2018) Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions. Neuropathol Appl Neurobiol 44, 550-562.</Citation></Reference><Reference><Citation>Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atares B, Puig B, Gomez-Esteban JC, Fernandez-Maiztegui C, Rouco I et al. (2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64, 1578-1585.</Citation></Reference><Reference><Citation>Munch C, Prechter F, Xu R, Linke P, Prudlo J, Kuzma M, Kwiecinski H, Ludolph AC and Meyer T (2005) Frequency of a tau genotype in amyotrophic lateral sclerosis. J Neurol Sci 236, 13-16.</Citation></Reference><Reference><Citation>Farhan SMK, Gendron TF, Petrucelli L, Hegele RA and Strong MJ (2017) ARHGEF28 p.Lys280Metfs40Ter in an amyotrophic lateral sclerosis family with a C9orf72 expansion. Neurol Genet 3, e190.</Citation></Reference><Reference><Citation>Zhang M, Xi Z, Ghani M, Jia P, Pal M, Werynska K, Moreno D, Sato C, Liang Y, Robertson J et al. (2016) Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28. J Neurol Neurosurg Psychiatry 87, 1268-1270.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>